Max India Limited (MAXIND) — Board Meeting | 11 August 2026(3 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approves CARE Ratings as Monitoring Agency for Rights Issue proceeds
🔄 What Changed
Appointment of Monitoring Agency and Audit Committee review authorization
💡 Investor Takeaway
The Board's approval ensures independent oversight of the Rights Issue fund usage, enhancing transparency for shareholders.

The Board approved the appointment of CARE Ratings Limited as the Monitoring Agency for the Rights Issue proceeds and authorized the Audit Committee to review its report, ensuring compliance with SEBI regulations and enabling oversight of fund utilization.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved expansion of senior living projects and AGEasy product launches
🔄 What Changed
Revenue up 66% YoY to Rs 68.6 crore; EBITDA loss narrowed to Rs 25 crore
🔮 What's Next
Continue focusing on profitable growth, cost optimization, and operationalizing Noida Phase I and Antara Dehradun
💡 Investor Takeaway
Revenue growth is strong YoY but profitability remains under pressure with a net loss of Rs 36.3 crore.

Max India reported Q1 FY27 revenue of Rs 68.6 crore, up 66% YoY but down 4.7% QoQ, with consolidated EBITDA loss narrowing to Rs 25 crore from Rs 23.2 crore YoY. Residences revenue rose to Rs 37.36 crore, assisted care services to Rs 30.61 crore, while the company posted a net loss of Rs 36.3 crore. The board approved continued expansion in senior living projects including Antara Dehradun and Noida Phase I, alongside product launches under AGEasy. Liquidity remains stable at Rs 21 crore cash with net worth at Rs 372 crore.

3 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved unaudited financial results and ESOP allotment
🔄 What Changed
Net loss of ₹3.86 crores reported for Q1 FY2026
💡 Investor Takeaway
The company posted a quarterly loss but highlighted non-material gains and rights issue proceeds.

The board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, showing a net loss of [amount context mismatch] crores and EPS of ₹(0.08), with total comprehensive income at ₹(3.96) crores. The Limited Review by Ravi Rajan & Co. LLP confirmed no material misstatements, while a rights issue generated ₹40 crores and included a ₹9.53 crore property sale gain. ESOP allotment of 60,000 shares and dissolution of Max UK Limited were also ratified.

About Max India Limited (MAXIND)

Financial Services · Finance · Listed on NSE

Market Cap: ₹823.08 Cr ROE: -37.0% ROCE: -33.0%

View full MAXIND stock details →

📡 Get AI alerts when MAXIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXIND — Free

📊 More MAXIND filings

See all MAXIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXIND files new disclosures

Track MAXIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXIND — Free

Free account · 2 AI queries/day